Teachers Retirement System of The State of Kentucky Has $71.32 Million Stake in HCA Healthcare, Inc. $HCA

Teachers Retirement System of The State of Kentucky boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 69.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 150,712 shares of the company’s stock after buying an additional 61,927 shares during the period. HCA Healthcare comprises 0.6% of Teachers Retirement System of The State of Kentucky’s portfolio, making the stock its 19th largest holding. Teachers Retirement System of The State of Kentucky’s holdings in HCA Healthcare were worth $71,324,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in HCA. State Street Corp raised its position in HCA Healthcare by 1.0% in the fourth quarter. State Street Corp now owns 7,566,643 shares of the company’s stock worth $3,532,563,000 after purchasing an additional 76,039 shares in the last quarter. Capital World Investors grew its stake in shares of HCA Healthcare by 0.8% in the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock valued at $2,334,040,000 after purchasing an additional 40,086 shares during the period. Geode Capital Management LLC boosted its stake in HCA Healthcare by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock valued at $1,702,738,000 after buying an additional 13,565 shares in the last quarter. Norges Bank acquired a new position in HCA Healthcare during the fourth quarter worth $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership boosted its stake in shares of HCA Healthcare by 11.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock valued at $1,078,966,000 after purchasing an additional 245,887 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

HCA has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft cut their price target on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a report on Tuesday, April 28th. Robert W. Baird cut their target price on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Royal Bank Of Canada decreased their price target on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Cantor Fitzgerald reduced their price objective on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 7th. Finally, Leerink Partners lowered their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Fourteen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $497.14.

HCA Healthcare Stock Performance

NYSE:HCA opened at $406.45 on Monday. The stock’s fifty day moving average price is $397.56 and its two-hundred day moving average price is $460.31. The company has a market cap of $90.17 billion, a price-to-earnings ratio of 13.98, a P/E/G ratio of 1.29 and a beta of 1.12. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company’s revenue was up 4.3% compared to the same quarter last year. During the same period last year, the company earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th were issued a $0.78 dividend. The ex-dividend date was Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.